Manufacturer: Aptalis Pharma Canada Inc.
Salofalk 500 mg gastro-resistant tablets contain the active substance mesalazine, an anti-inflammatory that is used in inflammatory bowel diseases.
Salofalk 500 mg gastro-resistant tablets are used for
the treatment and prevention (flare-ups) of acute episodes of a chronic inflammatory disease of the large intestine (colon) called by doctors ulcerative colitis.